Zepbound (tirzepatide) may produce greater weight loss than Saxenda or Wegovy
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg for 4 weeks and gradually titrated upward in 2.5 mg increments to minimize gastrointestinal side effects
Unopened vials: good until the expiration date printed on the label, typically 90 to 180 days from the compounding date
Other relative contraindications also exist, such as gallbladder disease or diabetic retinopathy
At Austin Plastic Surgeon, we have a BMI limit of 33 for our body contouring procedures
Patients with conditions affecting stomach acid production, gastroparesis, or inflammatory bowel disease may experience unpredictable absorption with tablets, making injections a more reliable choice